Cargando…
Combination of sapacitabine and HDAC inhibitors stimulates cell death in AML and other tumour types
BACKGROUND: Alternative treatments are needed for elderly patients with acute myeloid leukaemia, as the disease prognosis is poor and the current treatment is unsuitable for many patients. METHODS: In this study, we investigated whether combining the nucleoside analogue sapacitabine with histone dea...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990608/ https://www.ncbi.nlm.nih.gov/pubmed/20924380 http://dx.doi.org/10.1038/sj.bjc.6605922 |